Parthiban Brindha Devi

922 total citations · 1 hit paper
32 papers, 677 citations indexed

About

Parthiban Brindha Devi is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Parthiban Brindha Devi has authored 32 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 12 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Parthiban Brindha Devi's work include Tuberculosis Research and Epidemiology (16 papers), Biochemical and Molecular Research (6 papers) and Mycobacterium research and diagnosis (6 papers). Parthiban Brindha Devi is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Biochemical and Molecular Research (6 papers) and Mycobacterium research and diagnosis (6 papers). Parthiban Brindha Devi collaborates with scholars based in India, South Korea and Russia. Parthiban Brindha Devi's co-authors include Perumal Yogeeswari, Dharmarajan Sriram, Shalini Saxena, V. Ragunathan, Pawan Tiwari, Ganesh Samala, Jonnalagadda Padma Sridevi, Vijay Soni, Variam Ullas Jeankumar and Janupally Renuka and has published in prestigious journals such as Information Sciences, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Parthiban Brindha Devi

28 papers receiving 660 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease

2020 233 citations V. Ragunathan, Pawan Tiwari et al. Journal of Biomolecular Structure and Dynamics profile →

Peers

Countries citing papers authored by Parthiban Brindha Devi

Since Specialization

Citations

This map shows the geographic impact of Parthiban Brindha Devi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parthiban Brindha Devi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parthiban Brindha Devi more than expected).

Fields of papers citing papers by Parthiban Brindha Devi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parthiban Brindha Devi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parthiban Brindha Devi. The network helps show where Parthiban Brindha Devi may publish in the future.

Co-authorship network of co-authors of Parthiban Brindha Devi

This figure shows the co-authorship network connecting the top 25 collaborators of Parthiban Brindha Devi. A scholar is included among the top collaborators of Parthiban Brindha Devi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parthiban Brindha Devi. Parthiban Brindha Devi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Face-Gaze Biometric Fusion for Enhanced Personal Authentication 2024 ·Indian Journal of Science and Technology ·(unknown), Karthik Yamjala, Parthiban Brindha Devi, (unknown), (unknown)	0
2	Identification, characterization, and antibacterial studies of furobenzopyrans from Ammi visnaga 2023 ·Journal of Applied Pharmaceutical Science ·(unknown), Parthiban Brindha Devi	3
3	Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease breakdown → 2020 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), V. Ragunathan, Pawan Tiwari, (unknown), Parthiban Brindha Devi	233
4	A REVIEW ON PROTEIN TYROSINE PHOSPHATASES - AN IMPORTANT TARGET FOR VARIOUS DISEASES 2018 ·Asian Journal of Pharmaceutical and Clinical Research ·(unknown), Parthiban Brindha Devi, (unknown)	5
5	A REVIEW ON DNA NANOBOTS – A NEW TECHNIQUE FOR CANCER TREATMENT 2018 ·Asian Journal of Pharmaceutical and Clinical Research ·(unknown), Parthiban Brindha Devi, (unknown)	12
6	LITHISTID SPONGES DERIVED COMPOUNDS AND THEIR IMPORTANCE IN BIOLOGICAL RESEARCH - A REVIEW 2018 ·Asian Journal of Pharmaceutical and Clinical Research ·(unknown), Parthiban Brindha Devi	1
7	DOCKING STUDIES FOR VARIOUS ANTIBACTERIAL BENZILATE DERIVATIVES 2017 ·Asian Journal of Pharmaceutical and Clinical Research ·(unknown), Parthiban Brindha Devi, Charles C. Kanakam, (unknown)	4
8	PHARMACOPHORIC SCREENING OF VARIOUS ENDOPHYTIC FUNGAL METABOLITES 2017 ·Asian Journal of Pharmaceutical and Clinical Research ·Parthiban Brindha Devi, (unknown), (unknown)	3
9	Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis 2016 ·Bioorganic & Medicinal Chemistry ·Ganesh Samala, Parthiban Brindha Devi, Shalini Saxena, (unknown), Perumal Yogeeswari, Dharmarajan Sriram	10
10	Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Ganesh Samala, Parthiban Brindha Devi, Shalini Saxena, (unknown), Perumal Yogeeswari, Dharmarajan Sriram	55
11	Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis 2015 ·Tuberculosis ·Parthiban Brindha Devi, Jonnalagadda Padma Sridevi, (unknown), (unknown), Variam Ullas Jeankumar, Vijay Soni, (unknown), Perumal Yogeeswari, Dharmarajan Sriram	13
12	Investigating structure–activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59] 2014 ·International Journal of Mycobacteriology ·Ganesh Samala, (unknown), (unknown), Parthiban Brindha Devi, Jonnalagadda Padma Sridevi, Shalini Saxena, Perumal Yogeeswari, Dharmarajan Sriram	7
13	Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis 2014 ·European Journal of Medicinal Chemistry ·(unknown), Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, Shalini Saxena, Parthiban Brindha Devi, Janupally Renuka, Perumal Yogeeswari, Dharmarajan Sriram	26
14	Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus 2014 ·Bioorganic & Medicinal Chemistry ·Janupally Renuka, Variam Ullas Jeankumar, (unknown), Vijay Soni, Parthiban Brindha Devi, (unknown), Priyanka Suryadevara, (unknown), Pushkar Kulkarni, Perumal Yogeeswari, Dharmarajan Sriram	18
15	Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads 2014 ·Bioorganic & Medicinal Chemistry ·Ganesh Samala, Parthiban Brindha Devi, (unknown), Jonnalagadda Padma Sridevi, Shalini Saxena, Perumal Yogeeswari, Dharmarajan Sriram	32
16	Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors 2014 ·European Journal of Medicinal Chemistry ·Shalini Saxena, Ganesh Samala, Jonnalagadda Padma Sridevi, Parthiban Brindha Devi, Perumal Yogeeswari, Dharmarajan Sriram	31
17	Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·Ganesh Samala, (unknown), Parthiban Brindha Devi, Shalini Saxena, Renu Yadav, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram	28
18	Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors 2014 ·ChemMedChem ·Parthiban Brindha Devi, Ganesh Samala, Jonnalagadda Padma Sridevi, Shalini Saxena, Mallika Alvala, Elena G. Salina, Dharmarajan Sriram, Perumal Yogeeswari	26
19	Identification of novel inhibitors against Mycobacterium tuberculosis l-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening 2013 ·Journal of Molecular Graphics and Modelling ·Shalini Saxena, Parthiban Brindha Devi, Vijay Soni, Perumal Yogeeswari, Dharmarajan Sriram	34
20	Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors 2013 ·European Journal of Medicinal Chemistry ·Ganesh Samala, Parthiban Brindha Devi, (unknown), Perumal Yogeeswari, Dharmarajan Sriram	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact